Several pharmaceutical and life science companies are moving beyond the standard protocols to build action-oriented environmental, social and governance (ESG) efforts across their business ranging from clinical trials to supply chains. ESG is a crucial driver for capturing opportunities and remaining ahead of vulnerabilities.
Recommended Buyer's Guides
The integration of ESG strategy into clinical trials with regard to patient safety and privacy and in compliance with ethical and legal standards is bringing reform to the ways clinical trials are being conducted.
Discover the leading clinical trials ESG companies
Clinical Trials Arena has listed some of the leading companies offering products and services related to ESG using its intel, insights, and decades-long experience in the sector.
The information provided in the download document is drafted for clinical trial executives and technology leaders involved in ESG innovations.
The download contains detailed information on suppliers and their product offerings, as well as contact details to aid purchase or hiring decisions.
Amongst the leading suppliers of ESG in clinical trials are Medable, IQVIA, Eli Lilly, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, Biogen, Pfizer, and Bristol-Meyers Squibb.
How ESG is improving operational excellence in clinical trials?
ESG can address some of the biggest health-related challenges worldwide including access to healthcare. It can simplify the patient journey and extend accessibility across more diverse patient populations while safeguarding scientific integrity, which is critical to overall drug development.
The ESG initiatives can maximise trial efficiency through protocol automation and improve social elements by making it easier for patients to join clinical trials, irrespective of their location, mobility, and economic issues. It can help in improving the carbon footprint of pharmaceutical companies by various methods such as reducing the need for patients to travel.
Ways to improve diversity in clinical trials
Some of the key strategies for enhancing diversity in clinical trials during research and development of novel medicines within the pharmaceutical industry are generating clinical trial recruitment networks in underserved communities and establishing sustainable community-building efforts. These include investing in long-term health education while providing standardised platforms and engaging the community in conversations.
For full details (including contact details) on the leading companies within this space, download the free Buyer’s Guide below:
Frequently asked questions
-
What role does ESG play in clinical trials?
ESG (Environmental, Social, and Governance) practices in clinical trials focus on improving sustainability, ensuring ethical compliance, and promoting social responsibility. These initiatives aim to reduce the carbon footprint, ensure patient diversity and access, and promote transparent governance. ESG strategies can also streamline clinical operations, enhancing patient recruitment and retention through ethical engagement and fostering a positive environmental impact.
-
How do ESG initiatives enhance trial diversity?
ESG consultants help foster diversity by establishing recruitment networks in underserved communities, promoting inclusivity in clinical research, and engaging local populations to improve access to healthcare.
-
How does ESG impact sustainability in clinical trials?
ESG initiatives in clinical trials improve sustainability by minimising travel for participants through virtual trials and reducing the environmental impact of trial-related activities. This is done by using digital platforms and adopting green energy practices during trial operations, contributing to a reduced carbon footprint.
-
What is the governance component of ESG in clinical trials?
Governance in ESG ensures that clinical trials comply with ethical standards, regulatory guidelines, and transparent decision-making. It involves proper oversight of trial processes, ensuring compliance with global standards and promoting ethical treatment of patients.
-
Which companies provide ESG consulting for clinical trials?
Prominent ESG consultants in the clinical trials space include Medable, IQVIA, and Johnson & Johnson, offering guidance on integrating sustainability, social responsibility, and ethical practices into the clinical research process. These companies help organisations meet compliance and improve the overall impact of their trials on communities and the environment.